What is CorMedix Inc. (CRMD)?

CorMedix Inc. (CRMD) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of CRMD?

The current price of CRMD is $8.00. Prices are updated in real time on Stocks360.

What is CRMD's price-to-earnings (PE) ratio?

CRMD's trailing twelve-month PE ratio is 3.32, based on current price and earnings per share data available on Stocks360.

What is CRMD's market capitalization?

CRMD's market capitalization is $623,554,592.00, placing it in the small-cap tier.

CorMedix Inc. (CRMD)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$8.00

Market Cap

$623.55M

PE (TTM)

3.32

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.41

Day Range

$7.80 – $8.11

52-wk Range

$6.13 – $13.02

Avg Volume

N/A

Volume

1.00M

CorMedix Inc. (CRMD) is a publicly traded company in the Healthcare sector. Latest price: $8.00. Market cap $623.55M. Trailing PE 3.32. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $11.14 2026-10-27 · $8.00 (-28.19%)

Earnings

Most Recent

Aug 13, 2026

EPS $0.29 vs est. $0.24

Beat by $0.05

Next Earnings

Nov 11, 2026

EPS estimate $-0.10

Proprietary Signals

Signal snapshot temporarily unavailable.

About CorMedix Inc.

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	3.32×
P/S (TTM)	1.35×
P/B	1.36×
PEG	0.02×
P/FCF (TTM)	2.48×
EV / EBITDA	2.05×
EV / Sales	1.11×
Earnings Yield	29.83%
Free Cash Flow Yield	40.37%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$512.01M
Revenue (TTM)	$462.25M
Net Income (TTM)	$185.98M
Free Cash Flow (TTM)	$254.26M
Net Debt	-$111.54M
Working Capital	$293.16M
Gross Margin	82.78%
Operating Margin	46.95%
Net Margin	40.49%
Return on Equity	44.64%
Return on Invested Capital	27.87%